Integrated Psychoeducation Program for Internalized Stigma in Schizophrenia

Brief summary (registry, in English)

The goal of this pilot randomized controlled trial is to investigate whether the Integrated Psychoeducation Program reduces internalized stigma and improves related outcomes in adults with schizophrenia or schizoaffective disorder, and whether the program is feasible to deliver in a community mental health setting. The main question it aims to answer is: Do participants who receive the program show a greater reduction in internalized stigma from pre-test to post-test than participants in a waitlist control group who continue treatment as usual? Researchers will also examine changes in self-esteem, hopelessness, and psychological flourishing, whether changes are maintained at 3-month follow-up, and attendance and retention rates. Participants in the intervention group will attend 8 weekly group sessions that combine psychoeducation, an expressive writing exercise, and breathing/relaxation exercises. Participants in the waitlist control group will continue treatment as usual and will be offered the program after the study. All participants will complete questionnaires before the program (pre-tests), after the program (post-tests), and 3 months after the post-tests (3-month follow-up).

What you commit to

• Study type: Interventional
• Planned participants: 50
• From 21 Oct 2026 to the primary completion date, 25 Dec 2026
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.